GT Biologics Company Profile

22:18 EDT 17th March 2018 | BioPortfolio

GT Biologics is focused on the research and development of Live Biotherapeutics (LBPs) for the treatment of autoimmune diseases.

GT Biologics aim to deliver a new class of medicine based on the potent immune-regulating properties of novel bacterial isolates derived from the healthy human gut. We have completed a research-intensive innovative programme spanning several years investigating the immune-modulating activity of LBPs from early inception through to the proposed clinical development programme.

Since securing venture funding in 2012, GT Biologics have developed a strong product profile demonstrating potent anti-inflammatory effects in models of Inflammatory Bowel Disease. Our lead product, Thetanix™, is currently in development for Paediatric Crohn’s Disease.


Life Sciences Innovation Building
Cornhill Road
AB25 2ZS


Phone: +44(0)1224 437369

News Articles [482 Associated News Articles listed on BioPortfolio]

Medical News Today: What are biologics for RA?

Biologics work by targeting the specific immune system cells that cause rheumatoid arthritis. Learn more about biologics in this article.

WuXi Biologics Initiated cGMP Manufacturing in the World's Largest Biologics Manufacturing ...

In April 2015, WuXi Biologics announced a $150 millionplan to build a state-of-the-art biologics manufacturing facility in Wuxi city. In September 2016, Read more...

WuXi Biologics bets on China’s MAH scheme with new facility

Chinese biologics services provider WuXi Biologics (HK: 2269) recently started the operation of a new…

WuXi Biologics To Be ‘World’s No.1’ Biologics Maker

WuXi Biologics is aiming high to become the world’s biggest biologics manufacturer within five years after seeing strong confidence from...   

DSM Biologics: Karen King on New Technology and Reducing the Cost of Medicines

In this episode of PharmaTelevision News Review, Fintan Walton talks with Karen King, President and Business Unit Director of DSM Biologics. Filmed at BioChicago 2010 in Chicago, USA, they discuss: ...

#jobs #lifescience QA Specialist, Biologics

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: QA Specialist, Biologics .NJ-Princeton, Reporting to the QA Director or Biolo...

WuXi Biologics Initiates Mfg. at Largest SU Biologics Facility

The 500,000 sq.-ft. facility quintuples existing manufacturing capability and will support biologics commercial manufacturing

Heat Biologics, Inc.: Heat Biologics Adopts Stockholder Rights Plan

DURHAM, NC / ACCESSWIRE / March 12, 2018 / Heat Biologics, Inc. ("Heat" or the "Company") (NASDAQ: HTBX), a biopharmaceutical company developing drugs designed to activate a patient's immune system...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Standardized cat pelt [Jubilant HollisterStier LLC]


Standardized cat hair [Jubilant HollisterStier LLC]


Cinryze [ViroPharma Biologics]

These highlights do not include all the information needed to use CINRYZE™ safely and effectively. See full prescribing information for CINRYZE.CINRYZE™ (C1 Esterase Inhibitor [Human]) For Intrave...

PubMed Articles [97 Associated PubMed Articles listed on BioPortfolio]

Biologics for idiopathic inflammatory myopathies.

As treatment of refractory cases of idiopathic inflammatory myopathies (IIMs) has been challenging, there is growing interest in assessing novel biologics that target various pathways implicated in th...

Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.

Biologics have greatly improved psoriasis management. However, primary and secondary non-response to treatment requires innovative strategies to optimize outcomes.

Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma.

Recent efficacy studies of asthma biologics have included highly enriched patient populations. Using a similar approach, we examined factors that predict response to omalizumab to facilitate selection...


Many healthcare providers in the U.S. are not familiar with follow-on biologics and biosimilars nor with their critical distinctions from standard generics. Our aim is to provide a detailed review of ...

Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease.

Virtual biologics clinics are often used to review patients with inflammatory bowel disease receiving biological therapy, with decisions whether to continue, switch, or stop therapy made based on revi...

Clinical Trials [68 Associated Clinical Trials listed on BioPortfolio]

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

The patients included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health plan...

Golimumab Safety and Surveillance Program Using the Ingenix NHI Database

The participants included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health ...

Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease

"RUN-CD" is an investigator initiated "Non interventional Trial" on biologics in Crohn´s Disease (CD) patients in Germany with a prospective documentation of effectiveness in induction an...

Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity

Rationale/hypothesis: Moderate-to-severe psoriasis can be treated with biologics. Objective To investigate whether the dose of biologics can be reduced in patients with psoriasis with sta...

Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis

To estimate the real-world effectiveness of approved biologics in subjects with moderate-to-severe plaque psoriasis who are either starting or switching biologic medication.

Companies [243 Associated Companies listed on BioPortfolio]

Burst Biologics

Burst Biologics is a rapidly growing Biotechnology Company and federally registered tissue bank located in Boise, Idaho. Burst Biologics is a developer of effective tissue process...

MSD Biologics (UK) Limited

Avecia Biologics was acquired in February 2010 by MSD, the UK subsidiary of Merck & Co Inc, the world’s second largest pharmaceutical company. MSD Billingham is one of the world's leading contract ...

Precision Biologics, Inc.

Founded in February 2012 and commencing business in late September 2012, Precision Biologics, Inc. is a clinical stage biotechnology corporation focused on developing therapeutic ...

GT Biologics

GT Biologics is focused on the research and development of Live Biotherapeutics (LBPs) for the treatment of autoimmune diseases. GT Biologics aim to deliver a new class of medicine based on the po...

Permeon Biologics

Permeon Biologics is pioneering a breakthrough class of intracellular biologics that target a broad spectrum of previously undruggable targets. Leveraging its novel Intraphilinâ...

More Information about "GT Biologics" on BioPortfolio

We have published hundreds of GT Biologics news stories on BioPortfolio along with dozens of GT Biologics Clinical Trials and PubMed Articles about GT Biologics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GT Biologics Companies in our database. You can also find out about relevant GT Biologics Drugs and Medications on this site too.

Quick Search


Relevant Topics

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...

Corporate Database Quicklinks

Searches Linking to this Company Record